|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
p1282809 |
| 005 |
20230113043001.0 |
| 008 |
110531s2012 enka b 001 0 eng |
| 010 |
|
|
|a 2011021501
|
| 016 |
7 |
|
|a 101561697
|2 DNLM
|
| 016 |
7 |
|
|a 015955518
|2 Uk
|
| 019 |
|
|
|a 757478525
|
| 020 |
|
|
|a 9780470657348 (cloth)
|
| 020 |
|
|
|a 0470657340 (cloth)
|
| 029 |
1 |
|
|a NLM
|b 101561697
|
| 029 |
1 |
|
|a AU@
|b 000047378942
|
| 035 |
|
|
|a (OCoLC)728458320
|z (OCoLC)757478525
|
| 040 |
|
|
|a DNLM/DLC
|b eng
|c DLC
|d YDX
|d NLM
|d UKMGB
|d YDXCP
|d BDX
|d CDX
|d BTCTA
|d E7B
|d OCLCQ
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a MPAA
|
| 050 |
0 |
0 |
|a RM301.3.G45
|b P4235 2012
|
| 060 |
0 |
0 |
|a 2012 D-002
|
| 060 |
1 |
0 |
|a QV 38
|
| 082 |
0 |
0 |
|a 615.7
|2 23
|
| 245 |
0 |
0 |
|a Pharmacogenomics in clinical therapeutics /
|c edited by Loralie J. Langman, Amitava Dasgupta.
|
| 264 |
|
1 |
|a Chichester, West Sussex ;
|a Hoboken, NJ :
|b Wiley-Blackwell,
|c 2012.
|
| 300 |
|
|
|a ix, 244 pages :
|b illustrations ;
|c 26 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Pharmacogenomics principles : introduction to personalized medicine / Parvaz Madadi, and Gideon Koren -- Traditional therapeutic drug monitoring and pharmacogenomics : are they complementary? / Christine Snozek, Loralie J. Langman, and Amitava Dasgupta -- Pharmacogenomics aspect of warfarin therapy / Matthew D. Krasowski -- Pharmacogenetics and cancer chemotherapy / Christine L.H. Snozek -- Pharmacogenomic considerations in anesthesia and pain management / Christine Formea, Wayne T. Nicholson -- Pharmacogenomics of immunosuppressants / Nicolas Picard and Pierre Marquet -- Pharmacogenomics of cardiovascular drugs / Linnea M. Baudhuin -- Pharmacogenomics aspect of antiretroviral therapy / Natella Y. Rakhmanina and John N. van den Anker -- Pharmacogenetics of psychoactive drugs / Jorge L. Sepulveda -- Pharmacogenomic aspects of adverse drug-drug interactions / Loralie J. Langman and Christine Snozek -- Microarray technology and other methods in pharmacogenomics testing / Jorge L. Sepulveda -- Pharmacogenetic testing in the clinical laboratory environment / Mark P. Borgman and Mark W. Linder.
|
| 650 |
|
0 |
|a Pharmacogenetics.
|0 sh 85100595
|
| 650 |
|
0 |
|a Chemotherapy.
|0 sh 85023041
|
| 650 |
1 |
2 |
|a Pharmacogenetics
|x methods.
|0 D010597Q000379
|
| 650 |
2 |
2 |
|a Drug Therapy
|x methods.
|0 D004358Q000379
|
| 650 |
2 |
2 |
|a Pharmacological Phenomena
|x genetics.
|0 D000069437Q000235
|
| 700 |
1 |
|
|a Langman, Loralie J.
|0 n 2011182150
|
| 700 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|0 n 2007181514
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 100585552
|
| 938 |
|
|
|a Brodart
|b BROD
|n 13606964
|c $124.95
|
| 938 |
|
|
|a Coutts Information Services
|b COUT
|n 17843283
|
| 938 |
|
|
|a Baker and Taylor
|b BTCP
|n BK0010229630
|
| 951 |
|
|
|a 1282809
|
| 994 |
|
|
|a C0
|b MPA
|
| 999 |
f |
f |
|i 1f5cb488-0723-562d-8f4b-a57d66b8b8d3
|s 25b5fb90-bec7-5a1d-a036-235c4e7dd20d
|t 0
|
| 952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Boston Campus
|c MCPHS Boston Library
|d Boston Circulation
|t 0
|e RM301.3.G45 P4235 2012
|h Library of Congress classification
|i Book
|m 0113401795118
|
